Aims To examine perceptions of extended‐release (XR) buprenorphine injections among
people who regularly use opioids in Australia. Design Cross‐sectional survey prior to …

Introduction and Aims The dramatic increase in pharmaceutical opioid (PO) use in high‐income
countries is a growing public health concern. Stigma and social support are important as …

Aims. This paper (i) reviews the language used to describe and manage those patient
practices that fall outside standard medical models of opioid treatment (for pain and opioid …

Background There are increasing concerns regarding pharmaceutical opioid harms including
overdose and dependence, with an associated increase in treatment demand. People …

Background Interest in the use of cannabis and cannabinoids to treat chronic non-cancer pain
is increasing, because of their potential to reduce opioid dose requirements. We aimed to …

… Briony Larance has received untied educational grants from Reckitt Benckiser for two studies.
Reckitt Benckiser has no knowledge of, or role in, the development or writing of this article. …

Background Opioid dependence is associated with substantial health and social burdens,
and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for …

2. Methods Full details of the study design have been published elsewhere. 8 The study was
approved by the Human Research Ethics Committee of the University of New South Wales (…

Objective Benzodiazepines (BZDs) are commonly used by chronic pain patients, despite
limited evidence of any long-term benefits and concerns regarding adverse events and drug …

Objective There is increasing concern about the appropriateness of prescribing pharmaceutical
opioids for chronic non-cancer pain (CNCP), given the risks of problematic use and …